MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MNTK • US61218C1036

1.77 USD
+0.04 (+2.31%)
At close: Feb 4, 2026
1.77 USD
0 (0%)
After Hours: 2/4/2026, 8:00:01 PM
Fundamental Rating

2

Overall MNTK gets a fundamental rating of 2 out of 10. We evaluated MNTK against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. MNTK may be in some trouble as it scores bad on both profitability and health. MNTK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MNTK has reported negative net income.
  • In the past year MNTK had a positive cash flow from operations.
  • Of the past 5 years MNTK 4 years were profitable.
  • MNTK had a positive operating cash flow in each of the past 5 years.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • With a Return On Assets value of -2.40%, MNTK is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
  • MNTK has a Return On Equity (-3.53%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROIC N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • MNTK's Profit Margin has been stable in the last couple of years.
  • MNTK's Operating Margin has declined in the last couple of years.
  • The Gross Margin of MNTK (34.69%) is worse than 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of MNTK has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for MNTK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.69%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

  • MNTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MNTK has more shares outstanding
  • MNTK has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MNTK has been reduced compared to a year ago.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.68, we must say that MNTK is in the distress zone and has some risk of bankruptcy.
  • MNTK's Altman-Z score of 1.68 is fine compared to the rest of the industry. MNTK outperforms 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that MNTK is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.21, MNTK is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACCN/A
WACC8.33%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • MNTK has a Current Ratio of 0.33. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of MNTK (0.33) is worse than 95.00% of its industry peers.
  • MNTK has a Quick Ratio of 0.33. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MNTK (0.33) is worse than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

  • MNTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.00%.
  • The Earnings Per Share has been growing by 11.33% on average over the past years. This is quite good.
  • The Revenue for MNTK has decreased by -17.54% in the past year. This is quite bad
  • MNTK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.70% yearly.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.34% on average over the next years.
  • Based on estimates for the next years, MNTK will show a small growth in Revenue. The Revenue will grow by 5.09% on average per year.
EPS Next Y-60.34%
EPS Next 2Y1%
EPS Next 3Y36.62%
EPS Next 5Y6.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • MNTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 28.92, which means the current valuation is very expensive for MNTK.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MNTK indicates a somewhat cheap valuation: MNTK is cheaper than 70.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of MNTK to the average of the S&P500 Index (27.50), we can say MNTK is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 28.92
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • MNTK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MNTK is cheaper than 65.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.18
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MNTK's earnings are expected to grow with 36.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1%
EPS Next 3Y36.62%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

MONTAUK RENEWABLES INC

NASDAQ:MNTK (2/4/2026, 8:00:01 PM)

After market: 1.77 0 (0%)

1.77

+0.04 (+2.31%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-05
Earnings (Next)03-10
Inst Owners16.86%
Inst Owner Change-2.91%
Ins Owners53.73%
Ins Owner Change0%
Market Cap253.39M
Revenue(TTM)160.68M
Net Income(TTM)-9.20M
Analysts74.55
Price Target3.23 (82.49%)
Short Float %2.56%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.81%
Min EPS beat(2)-413.72%
Max EPS beat(2)180.11%
EPS beat(4)1
Avg EPS beat(4)-139.36%
Min EPS beat(4)-413.72%
Max EPS beat(4)180.11%
EPS beat(8)3
Avg EPS beat(8)-76.06%
EPS beat(12)3
Avg EPS beat(12)-77.59%
EPS beat(16)3
Avg EPS beat(16)-69.3%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)1.62%
Revenue beat(4)1
Avg Revenue beat(4)-13.09%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)1.62%
Revenue beat(8)2
Avg Revenue beat(8)-11.35%
Revenue beat(12)3
Avg Revenue beat(12)-12.63%
Revenue beat(16)5
Avg Revenue beat(16)-7.61%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)15.38%
EPS NQ rev (3m)25%
EPS NY rev (1m)333.3%
EPS NY rev (3m)203.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.92
P/S 1.58
P/FCF N/A
P/OCF 8.25
P/B 0.97
P/tB 1.05
EV/EBITDA 13.18
EPS(TTM)-0.06
EYN/A
EPS(NY)0.06
Fwd EY3.46%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.21
OCFY12.12%
SpS1.12
BVpS1.82
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.69%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 302.02%
Cap/Sales 52.34%
Interest Coverage N/A
Cash Conversion 131.56%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 1.68
F-Score3
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
EPS Next Y-60.34%
EPS Next 2Y1%
EPS Next 3Y36.62%
EPS Next 5Y6.34%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A
EBIT growth 1Y-112.86%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year2.44%
EBIT Next 3Y22.5%
EBIT Next 5Y5.16%
FCF growth 1Y-278.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.8%
OCF growth 3Y0.71%
OCF growth 5Y9.49%

MONTAUK RENEWABLES INC / MNTK FAQ

What is the ChartMill fundamental rating of MONTAUK RENEWABLES INC (MNTK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MNTK.


Can you provide the valuation status for MONTAUK RENEWABLES INC?

ChartMill assigns a valuation rating of 2 / 10 to MONTAUK RENEWABLES INC (MNTK). This can be considered as Overvalued.


How profitable is MONTAUK RENEWABLES INC (MNTK) stock?

MONTAUK RENEWABLES INC (MNTK) has a profitability rating of 2 / 10.


What is the expected EPS growth for MONTAUK RENEWABLES INC (MNTK) stock?

The Earnings per Share (EPS) of MONTAUK RENEWABLES INC (MNTK) is expected to decline by -60.34% in the next year.